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Abstract. 
 
Localization of 
 
bicoid
 
 (
 
bcd
 
) mRNA to the 
anterior and 
 
oskar
 
 (
 
osk
 
) mRNA to the posterior of the 
 
Drosophila
 
 oocyte is critical for embryonic patterning. 
Previous genetic studies implicated 
 
exuperantia
 
 (
 
exu
 
) in 
 
bcd
 
 mRNA localization, but its role in this process is 
not understood. We have biochemically isolated Exu 
and show that it is part of a large RNase-sensitive com-
plex that contains at least seven other proteins. One of 
these proteins was identiﬁed as the cold shock domain 
RNA-binding protein Ypsilon Schachtel (Yps), which 
we show binds directly to Exu and colocalizes with Exu 
in both the oocyte and nurse cells of the 
 
Drosophila
 
 egg 
chamber. Surprisingly, the Exu–Yps complex contains 
 
osk
 
 mRNA. This biochemical result led us to reexamine 
the role of Exu in the localization of 
 
osk
 
 mRNA. We 
discovered that 
 
exu
 
-null mutants are defective in 
 
osk
 
 
mRNA localization in both nurse cells and the oocyte. 
Furthermore, both Exu/Yps particles and 
 
osk
 
 mRNA 
follow a similar temporal pattern of localization in 
which they transiently accumulate at the oocyte ante-
rior and subsequently localize to the posterior pole. We 
propose that Exu is a core component of a large protein 
complex involved in localizing mRNAs both within 
nurse cells and the developing oocyte.
Key words: oogenesis • nurse cells • cold shock do-
main • 
 
oskar
 
 mRNA • 
 
exuperantia
 
Introduction
 
Localization of mRNAs is used by many polarized cells as
a means of restricting the distribution of a protein to a par-
ticular cytoplasmic domain (Bashirullah et al., 1998; Ha-
zelrigg, 1998; St Johnston, 1995). Whereas the types of
localized transcripts vary, mRNA localization in all sys-
tems shares several common features (Wilhelm and Vale,
1993; Macdonald and Smibert, 1996; Bassel and Singer,
1997; Gavis, 1997; Oleynikov and Singer, 1998). First, the
cis-acting mRNA localization elements generally reside
within the 3
 
9
 
 untranslated region (UTR)
 
1
 
 (Kislauskis and
Singer, 1992; Bashirullah et al., 1998). Second, the trans-
port of localized messages from the nucleus to their final
destinations occurs along either actin filaments or micro-
tubule tracks. Third, transcripts are anchored at their sites
of localization through attachments to cytoskeletal ele-
ments and then activated for translation. Although these
phenomena have been well-documented, their molecular
bases remain poorly understood.
One of the most extensively characterized systems for
studying mRNA localization is the 
 
Drosophila
 
 oocyte. In
the 
 
Drosophila
 
 egg chamber, an oocyte is linked to 15
nurse cells by a network of cytoplasmic bridges called ring
canals (Spradling, 1993). The nurse cells synthesize vari-
ous mRNAs that are required for early embryogenesis,
such as the 
 
bicoid 
 
(
 
bcd
 
) and 
 
oskar 
 
(
 
osk
 
) transcripts, and
transport them in a microtubule-dependent manner to dis-
crete locations within the oocyte (Pokrywka and Stephen-
son, 1991, 1995). 
 
bcd
 
 mRNA is localized to the anterior of
the oocyte (Berleth et al., 1988), and the resulting ante-
rior–posterior gradient of the Bcd homeodomain protein
initiates a series of concentration-dependent transcrip-
tional programs that establish the anterior pattern of the
embryo (St Johnston and Nusslein-Volhard, 1992). In con-
trast, 
 
osk 
 
mRNA is transported from the nurse cells to the
anterior of the oocyte, but is ultimately localized to the
posterior of the oocyte where it becomes stably anchored
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(Ephrussi et al., 1991; Kim-Ha et al., 1991). The Osk pro-
tein synthesized at this location recruits a number of addi-
tional components that are required for the formation of
the abdomen and germ cells (Ephrussi et al., 1991; Smith
et al., 1992; Kobayashi et al., 1995; Breitwieser et al.,
1996).
Genetic screens have identified several mutants that
have patterning defects due to the mislocalization of 
 
bcd
 
and/or 
 
osk
 
 mRNAs. Mutations in some genes, such as
 
swallow
 
 and 
 
staufen
 
, cause only partial disruption of 
 
bcd
 
mRNA localization late in oogenesis (Berleth et al., 1988;
Stephenson et al., 1988; St Johnston et al., 1989, 1991).
However, in 
 
exuperantia
 
 (
 
exu
 
) mutants, defects in 
 
bcd
 
mRNA localization occur early in oogenesis and result in
 
bcd
 
 mRNA being uniformly distributed in the mature oo-
cyte (Berleth et al., 1988; St Johnston et al., 1989). Time-
lapse confocal microscopy has further shown that green
fluorescent protein (GFP)-Exu forms particles that move
in a microtubule-dependent manner and accumulate at the
anterior and posterior of the oocyte (Theurkauf and Ha-
zelrigg, 1998). Immunoelectron microscopy has also re-
vealed that Exu is a component of large electron-dense
structures called sponge bodies (Wilsch-Brauninger et al.,
1997). However, all of these previous studies have not de-
termined whether Exu is associated with transported
mRNAs or whether its role is more indirect, such as in de-
livering material required for anchoring mRNA to the oo-
cyte anterior.
Various studies have shown that localized messages are
organized into particles (Ferrandon et al., 1994; Ainger
et al., 1993; Bertrand et al., 1998), suggesting that a large
protein complex may be involved in recognizing, trans-
porting, and anchoring localized messages. However, iden-
tifying the proteins associated with localized mRNAs has
been a difficult undertaking. Previous biochemical studies
uncovered proteins that specifically recognize the RNA
localization sequences in the 3
 
9
 
 UTR of mRNAs (Mac-
Donald et al., 1995; Deshler et al., 1997; Ross et al., 1997;
Havin et al., 1998; Hoek et al., 1998; Cote et al., 1999).
However, their roles in mRNA transport have not been
confirmed by genetic analyses. An alternative strategy is
to isolate the native RNA complexes involved in mRNA
transport and then identify the associated proteins. To
achieve this goal, we thought that the Exu protein might
provide a useful biochemical handle for the purification of
an mRNA transport particle. In this study, we demon-
strate that Exu exists in a large RNase-sensitive complex
with at least seven other proteins, one of which is a cold
shock domain RNA binding protein. Unexpectedly, 
 
osk
 
mRNA is present in the Exu complex, and we have discov-
ered that Exu is involved in posterior mRNA localization
in addition to its previously described role in localizing
mRNAs to the anterior. We propose that Exu is part of a
core complex that localizes both 
 
osk
 
 and 
 
bcd
 
 mRNAs
within nurse cells and the developing oocyte.
 
Materials and Methods
 
Drosophila Stocks
 
Oregon R (Ore) was the wild-type stock used for antibody staining and
generation of wild-type 
 
Drosophila
 
 extracts. Females from NG5/NG5;
 
Sco/SM1, which contains an X-linked insertion of a P[CasNGE] 
 
gfp-exu
 
transgene (Wang and Hazelrigg, 1994), were used for double labeling of
Ypsilon Schachtel (Yps) and Exu. For biochemical analysis, flies bearing a
 
gfp-exu-his
 
6
 
 transgene (16b-16) were used.
To construct the 
 
gfp-exu-his
 
6
 
 transgene, the 5.5-kb SmaI-EcoRI 
 
exu
 
 ge-
nomic fragment was subcloned into pBlueScript II (SK) (Stratagene), to
create pBS–
 
exu
 
5.5. pBS–
 
exu
 
5.5 was used as the template for in vitro mu-
tagenesis to introduce BstEII and SphI restriction sites immediately up-
stream of 
 
exu
 
’s translation start codon (using the Biorad Muta-Gene kit).
Simultaneously, an 18-bp insertion encoding six histidine codons was in-
troduced just upstream of 
 
exu
 
’s stop codon. Correctly mutagenized plas-
mids were identified by restriction analysis for the presence of the BstEII
and SphI sites, and DNA sequence analysis for the presence of the 18-bp
his-encoding insertion. A 700-bp BstEII-SphI 
 
gfp
 
 fragment was excised
from pEG1 (Wang and Hazelrigg, 1994), and subcloned into the BstEII
and SphI sites of this mutagenized
 
 exu
 
 fragment. The resulting 6.2-kb 
 
gfp-
exu-his
 
6
 
 fragment was then excised by SmaI and EcoRI digestion and in-
serted into pCasPeR4 through its StuI and EcoRI cloning sites to create
pWG16b. P-element transformation followed standard injection protocols
(Spradling and Rubin, 1982), with transposase activity provided by the re-
cipient strain (
 
y w; Sb 2-3/TM6
 
). A transformant line bearing an insertion
on the X chromosome was established (
 
w, 16b-16
 
), and genetic crosses
with an 
 
exu
 
SCO2
 
/
 
CyO
 
 strain determined that the 
 
gfp-exu-his
 
6
 
 
 
transgene
rescued the female sterility associated with the 
 
exu
 
SCO2 
 
mutation.
 
Extract Preparation
 
Extracts were prepared by flash freezing 50–60 ml of flies in liquid N
 
2
 
. The
frozen flies were ground to a fine powder with a prechilled mortar and
pestle, with regular additions of liquid N
 
2
 
 to keep the sample frozen. The
fly powder was degassed for 5–10 min on ice in a 50-ml Falcon tube and
mixed either 1:1 or 1:2 with 
 
Drosophila
 
 extract buffer (DXB: 25 mM
Hepes, pH 6.8, 50 mM KCl, 1 mM MgCl
 
2
 
, 1 mM DTT, 250 mM sucrose)
containing 10 
 
m
 
g/ml aprotinin, leupeptin, pepstatin, and 1 mM PMSF. The
extracts were homogenized with 10 strokes of the B dounce in a 50-ml
dounce homogenizer, followed by 10 strokes of the A dounce, and then
centrifuged at 10,000 
 
g 
 
for
 
 
 
15 min at 4
 
8
 
C in the Beckman TLX ultracentri-
fuge. The supernatant was collected and centrifuged a second time. The
supernatant from the second spin was collected, aliquoted, frozen in liquid
N
 
2
 
, and stored at 
 
2
 
80
 
8
 
C. Hand dissected extracts were prepared by dis-
secting 50 ovaries into 0.7 ml of modified 
 
Drosophila
 
 extract buffer
(mDXB: 25 mM Hepes, pH 6.8, 50 mM KCl, 1 mM MgCl
 
2
 
, 1 mM DTT,
125 mM sucrose) containing 10 
 
m
 
g/ml aprotinin, pepstatin, leupeptin, and
1 mM PMSF. The sample was then homogenized with 15 strokes in a 2-ml
dounce homogenizer (Wheaton, Inc.) at 4
 
8
 
C. The extract was centrifuged
at 10,000 
 
g
 
 for 10 min at 4
 
8
 
C to collect the supernatant.
 
Sucrose Density Gradient Analysis of Exu Complex
 
Extract from hand dissected ovaries (250 
 
m
 
l) was loaded on a 5-ml 5–40%
sucrose gradient made with DXB containing 10 
 
m
 
g/ml leupeptin, pep-
statin, and aprotinin. For frozen 
 
Drosophila
 
 extracts, 150 
 
m
 
l of 
 
z
 
10 mg/ml
extract was diluted 1:1 with sucrose-free DXB containing 10 
 
m
 
g/ml pep-
statin, leupeptin, aprotinin, and 1 mM PMSF. The diluted extract was cen-
trifuged at 10,000 
 
g
 
 for 5 min in a microcentrifuge and the supernatant
loaded on a 5-ml 5–40% sucrose gradient. The gradients were centrifuged
at 237,000 
 
g
 
 for 4 h in a Beckman SW-55 rotor. 300-
 
m
 
l fractions were col-
lected from the gradient and precipitated with 1/10 volume TCA using 20 
 
m
 
g
aprotinin as a carrier. The precipitate was resuspended in 30 
 
m
 
l sample
buffer and 15 
 
m
 
l was loaded onto SDS-PAGE gel for immunoblot analy-
sis. For RNase shift experiments, the extract (250 
 
m
 
l) was either treated
with 2.5 
 
m
 
g of RNase A for 10 min at 4
 
8
 
C, followed by addition of 2,000 U
of RQ1 RNasin (Promega), or treated for 10 min at 4
 
8
 
C with 2.5 
 
m
 
g of
RNase A that had been preincubated with 2,000 U of RQ1 RNasin. These
samples were loaded onto a 5-ml 10–40% sucrose gradient and centri-
fuged as above.
 
Two-Step Purification of GFP-Exu-His
 
6
 
5 ml of 
 
z
 
10 mg/ml 
 
Drosophila
 
 extract (made with 5 mM 
 
b
 
-mercaptoetha-
nol instead of 1 mM DTT) were incubated with 0.5 ml of Ni-NTA resin in
the presence of 0.1% Triton X-100 for 1 h at 4
 
8
 
C. The resin was washed
once in batch with 10 ml of DXB150 (DXB with 150 mM KCl) supple-
mented with 0.1% Triton X-100 (wash 1) followed by a 10-ml column
wash (wash 2). The column was eluted with 250 mM imidazole in 
Wilhelm et al. 
 
RNP Complex Involved in mRNA Localization
 
429
 
DXB150, and 0.5-ml fractions collected. The peak fractions were pooled
and immunoprecipitated as described.
 
Antibody Generation
 
The full-length coding region and the first 160 amino acids of Yps
(Yps160) were each cloned into pGEX-2T and expressed as COOH-ter-
minal fusions to glutathione 
 
S
 
-transferase (GST) in
 
 E. coli
 
. Soluble GST-
Yps and GST-Yps160 were purified on a glutathione affinity column,
eluted with glutathione, and injected into rabbits (antiserum production
by BABCO). GST-Yps did not express as a full-length protein in 
 
E. coli
 
,
but rather yielded a protein product 
 
z
 
10 kD larger than GST-Yps160.
Antisera to GST-Yps160 was affinity purified by preabsorption on an
Affi-Gel column coupled with GST, followed by affinity purification with
an Affi-Gel column coupled with GST-Yps160. This affinity purified anti-
body was used for all experiments except for those shown in Fig. 8, C and
D, where the GST-Yps antisera was used. The antisera against GST-Yps
gave identical results to the affinity purified anti-Yps160 antibody in im-
munofluorescence experiments.
GFP was expressed in 
 
E. coli
 
 and purified on a Q-Sepharose column
followed by a phenyl Sepharose column. The purified GFP was injected
into rabbits for antisera production (BABCO). Antisera to GFP was af-
finity purified with an Affi-Gel column coupled with GFP. This antibody
recognizes GFP in both immunoblots and immunoprecipitations.
Antisera against a peptide (NRRGGRQSVKDARPSSC; amino acids
422–437) from Exu were generated (QCB, Inc.) and affinity purified with
peptide coupled to Sulfolink gel (Pierce, Inc.). This affinity purified anti-
body recognizes Exu in both immunoblots and immunoprecipitations.
 
Immunoblots
 
For immunoblot analysis, samples were run on SDS–polyacrylamide gels
and then transferred to nitrocellulose by semidry transfer. The membrane
was blocked in TBS (20 mM Tris-Cl, pH 7.5, 200 mM NaCl), 0.1% Tween
20, 10% nonfat dry milk, and then incubated with either 1:2,000 dilution of
anti-Exu rabbit antibody (gift of Paul MacDonald, University of Texas at
Austin, Austin, TX) or 5 
 
mg/ml of affinity purified anti-Yps rabbit anti-
body in TBS, 0.1% Tween 20, 5% BSA. Protein was detected by chemilu-
minescence using HRP-conjugated donkey anti–rabbit Ig (Amersham
Pharmacia Biotech) diluted 1:2,500 in TBS containing 0.1% Tween 20 and
5% BSA.
Immunoprecipitations of Yps and GFP
125 ml of protein A agarose beads (GIBCO BRL) was washed six times
with PBS (137 mM NaCl, 2.6 mM KCl, 10 mM NaHPO4, 1.7 mM
KH2PO4) 1 0.1% Triton X-100 (PBST). 50 mg of antibody was added to
the beads in a final volume of 300 ml and mixed for 30 min at room tem-
perature. The beads were washed once with PBST followed by two
washes with 0.2 M sodium borate, pH 9.0. Dimethyl pimelidate was then
added to a final concentration of 20 mM and the sample mixed for 1 h at
room temperature. The beads were washed three times with 0.2 M etha-
nolamine, pH 8.0, and mixed for 2 h at room temperature. The beads were
preeluted with three 1-ml washes of 100 mM glycine, pH 2.5, followed by
three washes with DXB.
Fresh 10 mg/ml leupeptin, pepstatin, and 1 mM PMSF were added to 1 ml
of frozen Drosophila extract (z10 mg/ml) and centrifuged at 10,000 g for
5 min in a microcentrifuge. 850 ml of supernatant was immunoprecipitated
with 50 ml of antibody-coated beads for 1 h at 48C with gentle shaking.
The beads were washed four times with DXB containing 10 mg/ml leupep-
tin, pepstatin, and 1 mM PMSF and then eluted with two 150-ml washes
and one 200-ml wash of 100 mM glycine, pH 2.5. The elutions were neu-
tralized with 200 ml of 0.5 M Hepes, pH 7.6, and any residual beads re-
moved by centrifuging at 10,000 g for 5 min in a microcentrifuge. The su-
pernatant was precipitated with 1/10 volume TCA in the presence of 20 mg
aprotinin as a carrier. The sample was resuspended in sample buffer for
further analysis. When RNase sensitivity of the immunoprecipitation was
assayed, the incubation of extract with antibody-coated beads was per-
formed in the presence of 300 mg of RNase A. Immunoprecipitations of
the Exu complex from sucrose gradients were performed on fractions
pooled from five 5–40% sucrose gradients loaded with frozen Drosophila
extract using our standard conditions (see above).
Microsequence Analysis of p57/Yps
p57 was immunoprecipitated as described, separated by SDS-PAGE, and
then stained with Coomassie blue. After removing the protein band, an in-
gel digestion with Endoproteinase Lys-C (Roche Diagnostics) was carried
out as described (Hellman et al., 1995). Gel-extracted peptides were then
fractionated using a Vydac microbore C8 column (The Separations
Group), and individual peptides subjected to Edman degradation with
a protein sequencer, Model 492 (PerkinElmer Biosystems). BLAST
searches with these peptides identified p57 as Yps. Six expressed sequence
tags (ESTs) corresponding to yps (GM14045, LD01826, GM03816,
LD18388, GM02535, LD01538) were obtained (Berkeley Drosophila Ge-
nome Project/Howard Hughes Medical Institute EST Project) and se-
quenced.
Immunoprecipitations for Reverse Transcribed–PCR
Immunoprecipitations were carried out as above, but the antibody was
not cross-linked to the protein A agarose beads (GIBCO BRL). Beads
were washed four times with DXB200 (DXB, with 200 mM KCl) contain-
ing 10 mg/ml leupeptin, pepstatin, and 1 mM PMSF. Beads were then re-
suspended in 200 ml buffer (100 mM Hepes, pH 6.8, 150 mM NaCl, 12.5 mM
EDTA, 1% SDS) and heated to 658C for 10 min. The beads were pelleted
and the supernatant from two immunoprecipitations was phenol/chloro-
form-extracted followed by an ethanol precipitation using 20 mg glycogen
as carrier. The pellet was resuspended in 50 mM Hepes, pH 6.8, 1 mM
MgCl2 and treated with 10 U RQ1 DNase I (Promega) for 30 min at 378C.
The sample was then phenol/chloroform-extracted, and ethanol-precipi-
tated a second time. The RNA sample was reverse transcribed (RT) using
the Superscript preamplification system (GIBCO BRL), and 2 ml of 10-,
100-, and 1,000-fold dilutions of the RT product were amplified in a 50-ml
PCR reaction (20 mM Tris-HCl, pH 8.4, 50 mM KCl, 1.5 mM MgCl2, 1
mM dNTPs, 2.5 U Taq polymerase, 15 pmol primer). Cycling conditions
were 5 min at 958C, followed by 40 cycles of 1 min at 958C, 1 min at 558C,
and then 1 min at 728C. Primers were tested by using the same RT-PCR
conditions as above, except 5 mg of total RNA from extracts was used in
the RT reaction and only 30 cycles of PCR were performed. The primers
used were: bcd2761, 59-gtcggatcctgggtcgaccaatgtcaatggcg-39; bcd3738, 59-
gtcgaattcgctcttgtccagacccttcaaagg-39; osk860, 59-gtcggatccaatggaatcacgat-
atcgagcatca-39; osk1630, 59-gtcgaattcttacgctggcttgctggtagaaat-39; nos1110,
59-gtcggatccgatccttgaaaatctttgcgcaggt-39; nos2221, 59-gtcgaattctcgttgttat-
tctcacaaaagacgca-39; pgk1800, 59-gtcggatccgccaagaagaataacgtgcagttgc-39;
and pgk2280, 59-gtcgaattccgctggtcaatgcacgcacgc-39. RT-PCR primers were
designed for osk, nanos (nos), and bcd to span an intron to easily separate
RT-PCR products from products that were amplified due to genomic con-
tamination. Products for osk, nos, and bcd were subcloned and their iden-
tity confirmed by DNA sequencing.
Immunofluorescence
0–1-d-old females were collected and fed for 1–2 d with dried baker’s
yeast, in the presence of males. Ovaries were dissected into PBT and fixed
in 600 ml of heptane and 100 ml of fixative (6% formaldehyde, 16.7 mM
KPO4 pH 6.8, 75 mM KCl, 25 mM NaCl, 3.3 mM MgCl2) rocking at room
temperature for 9 min. The ovaries were then washed several times in
PBT, for a total of 15 min. Ovaries were permeabilized in PBT for 5 h,
blocked in 0.5% BSA in PBT for 30 min, and incubated in a 1:500 dilution
of the primary antibody in PBT overnight at 48C. The secondary antibody
(rhodamine-conjugated goat anti–rabbit Fab fragments; Jackson Immu-
nochemical Research, Inc.) was simultaneously preabsorbed to fixed ova-
ries at a dilution of 1:500 in PBT overnight at 48C. After removal of the
primary antibody, the ovaries were washed in PBT (five times for 5 min)
at room temperature, and incubated in the preabsorbed secondary anti-
body for 3 h at room temperature. The ovaries were then washed in PBT
(five times for 5 min), and either mounted in 20 ml Fluoromount-G
(Southern Biotechnology Associates, Inc.) or incubated overnight in 60%
glycerol in PBT at 48C, then mounted in 40 ml of 60% glycerol. Imaging
was performed on a Biorad MRC600 laser confocal unit attached to a
Zeiss Axioplan microscope.
Binding Assays for In Vitro Translated Exu and Yps
Site-directed mutagenesis and PCR were used to create unique restriction
sites in order to attach NH2-terminal epitope tags in-frame to exu and yps
cDNAs. DNA encoding the 33 myc tag was obtained from T7myc-Gsp1wt
vector (gift of Erin O’Shea, University of California, San Francisco, San
Francisco, CA) and joined to the 59 end of yps. DNA encoding the 33 he-
magglutinin (HA) tag was obtained from the pGTEP vector (gift of Joachim
Li, University of California, San Francisco) and joined to the 59 end of exu.The Journal of Cell Biology, Volume 148, 2000 430
Each of the two fusions was then subcloned into the NcoI and EcoRI sites of
the pSPBPI transcription vector (gift of Vishu Lingappa, University of Cali-
fornia, San Francisco); this vector was derived from pSP64 and includes a 59
UTR and strong Kozak consensus region from Xenopus globin cDNA.
A coupled transcription–translation system (Promega) was used to in
vitro translate tagged Exu and Yps. 600 ng of plasmid DNA was added to
a 50-ml transcription–translation mix. The myc-Yps transcription–transla-
tion mix contained [35S]methionine (Translabel; ICN), whereas the HA–
Exu mix did not. After a 90-min incubation at 308C, 0.5 ml of 400 nM
7-methylguanosine 5-monophosphate (CAP Analogue) and 5 ml of 10 mg/ml
RNase A were added to each reaction. 5 ml of radiolabeled myc-Yps was
either incubated alone or mixed with cold HA–Exu and coincubated for
30 min at room temperature. Afterwards, 490 ml of DXBT250 (DXB con-
taining 250 mM KCl and 0.1% Triton X-100) was added to the coincuba-
tion mixes before the immunoprecipitations.
For immunoprecipitations, 0.5 ml of anti-HA (16S12 monoclonal; gift of
Dave Morgan) was added to translations and set on a rotator at 48C for 60
min. A 30-ml slurry containing 10 ml of protein A beads (Life Technolo-
gies, Inc.) was added to the translation–antibody mix and incubated for
another 60 min at 48C on a rotator. The beads were then pelleted in a low-
speed microfuge for 2 min and the supernatant was removed. After wash-
ing with DXBT250 (three times in 1 ml), the beads were resuspended in
SDS sample buffer and boiled for 5 min. 7.5 ml was loaded on 4–12% SDS-
PAGE gel and processed for autoradiography.
osk In Situ Hybridization
Whole mount in situ hybridization to ovaries was performed as described
previously (Tautz and Pfeifle, 1989) with several modifications. Ovaries
from well-fed, 2–3-d-old females raised at 188C (Oregon R or exuSC02/
Df[2]MK1) were dissected into PBT and fixed for 15 min in 8:1:1 (4%
paraformaldehyde in PBT/Clorox bleach/dimethyl sulfoxide). The ovaries
were washed twice for 5 min in PBT, and 5 min each in 3:1, 1:1, and 1:3
PBT/methanol, then twice for 5 min in methanol, and stored at 2208C.
Before hybridization, the ovaries were rehydrated into PBT by 5-min
washes in 3:1, 1;1, 1:3 methanol/PBT and twice for 5 min in PBT. After
teasing apart the ovarioles slightly, the ovaries were treated for 15 min
with 50 mg/ml proteinase K (Boehringer Mannheim) in PBT, washed
twice quickly in PBT, and postfixed for 10 min in 4% paraformaldehyde in
PBT. After five 5-min washes in PBT, the ovaries were equilibrated into
hybridization buffer (HB: 53SSC, 0.1% Tween 20, 50 mg/ml heparin, 0.1
mg/ml denatured salmon sperm DNA, 50% formamide) by 5-min incuba-
tions in 3:1, 1:1, and 1:3 PBT/HB, followed by a 1-h incubation at 458C in
HB. Hybridization was done in 10 ml of probe in HB (see below) over-
night at 458C. Excess probe was removed by three 20-min washes in HB,
followed by 10-min washes in 3:1, 1:1, and 1:3 HB/PBT, all at 458C. The
ovaries were then washed five times for 5 min in PBT at room tempera-
ture, then incubated in an alkaline phosphatase–conjugated antidigoxyge-
nin antibody (Boehringer Mannheim) at a dilution of 1:2,000 in PBT for 1 h.
Before incubation, the antibody was preabsorbed to fixed ovaries for at
least 1 h. The ovaries were washed five times for 5 min in PBT and twice
for 5 min in alkaline phosphatase staining buffer (100 mM NaCl, 50 mM
MgCl2, 100 mM Tris, pH 9.5, 0.1% Tween 20). For antibody detection, 1 ml
alkaline phosphatase staining buffer, 4.5 ml 4-nitro blue tetrazolium chlo-
ride, and 3.5 ml X-phosphate (Boehringer Mannheim) were added to the
ovaries and incubated 3–10 min. We found that a short staining time was
crucial in order to prevent saturation of the color reaction, which masked
differences between the genotypes. The ovaries were then washed several
times in PBT for a total of 45 min and equilibrated overnight at 48C in
60% glycerol. Ovaries were mounted in 60% glycerol and visualized on a
Nikon Eclipse E800 microscope with a Nikon Plan Fluor 203 objective,
under Nomarski optics. Photographs were taken with a Nikon FX-35WA
camera on Kodak Elite Chrome slide film, and scanned into Adobe Pho-
toshop with a Polaroid SprintScan 35 slide scanner.
Probes were prepared by labeling a plasmid containing the osk cDNA,
PNBosk7 (courtesy of R. Lehmann, Skirball Insitiute, New York Univer-
sity Medical Center, New York, NY) with dig-dUTP using DIG-Nick
Translation Mix (Boehringer Mannheim). After ethanol precipitation, the
probe was resuspended in 100 ml HB. Just before use, the probe was dena-
tured by boiling for 5 min, and cooled on ice.
Results
Exu Exists in a Large RNase-sensitive Complex
To define the biochemical properties of Exu, we deter-
mined its size in Drosophila extracts using sucrose density
gradients. In extracts made from either hand dissected
ovaries (Fig. 1 A) or whole flies that were frozen in liquid
N2 (data not shown), Exu migrated in a very broad distri-
bution with a significant fraction of Exu migrating larger
than 20 S (Fig. 1 A). In contrast, in vitro–translated Exu
sedimented at 4.5 S, the value expected of a monomeric
58-kD protein (data not shown). Therefore, the large size
of Exu in Drosophila extracts must be due to its asso-
ciation with additional proteins and/or RNAs. To test
whether the Exu complex contains RNA, the extract was
treated with RNase A before sedimentation analysis. This
treatment caused the complex to migrate as a 7-S species;
this shift was not due to proteolysis, since a control reac-
tion in which RNase A was premixed with RNase inhibitor
did not affect Exu migration (Fig. 1 B). These results dem-
onstrate that Exu is associated with a large RNA-contain-
ing complex.
Figure 1. RNase-sensitive
sedimentation of Exu in
Drosophila extracts. (A) Sed-
imentation of Exu from an
extract made from hand dis-
sected ovaries through a
5–40% sucrose gradient (see
Materials and Methods). This
immunoblot shows a broad
distribution of Exu signal
with the majority sediment-
ing  .20 S. (B) Sedimentation
of Exu in extracts treated with
RNase A (10 mg/ml, 10 min at
48C) followed by addition of
pancreatic RNase inhibitor
(8,000 U/ml) (upper panel).
As a control, RNase A was
premixed with the inhibitor before addition to the extract (lower panel). When RNase A is added first, the Exu immunoblot signal shifts
from a large broad distribution to a tight 7-S peak. Although there is some variability in the sedimentation profile of Exu from extract to
extract, there is always a significant fraction of Exu sedimenting at 20 S or greater.Wilhelm et al. RNP Complex Involved in mRNA Localization 431
The RNA-binding Protein Yps Copurifies with Exu
To identify the protein components of the Exu complex,
GFP-Exu was immunoprecipitated from whole fly extracts
prepared from a GFP-Exu–expressing fly line using an
anti-GFP antibody. The GFP tag does not impair Exu pro-
tein function, since the gfp-exu transgene fully comple-
ments a null allele of exu (exuSCO2) (Wang and Hazelrigg,
1994). Fig. 2 shows that seven polypeptides of 57, 74, 76,
78, 82, 88, and 147 kD coimmunoprecipitated specifically
with GFP-Exu, but not with control IgG-coated beads. A
similar set of polypeptides coimmunoprecipitated with
GFP-Exu from an extract made from hand dissected ova-
ries, indicating that this complex is present within the
female germ line (data not shown). This same set of
polypeptides also coimmunoprecipitated with Exu from
wild-type fly extracts using an antibody directed against a
COOH-terminal peptide of Exu (data not shown; see
Materials and Methods). Of the coimmunoprecipitated
proteins, the 57-, 74-, 76-, 78-, and 82-kD proteins were
present in amounts comparable to that of GFP-Exu,
whereas the 88- and 147-kD proteins were clearly sub-
stoichiometric. When the extract was extensively treated
with RNase A, only the 57-kD protein remained associ-
ated with GFP-Exu (Fig. 2). Taken together with our gra-
dient analysis (Fig. 1 B), these results suggest that Exu and
p57 are components of a 7-S RNase-resistant core com-
plex; the other polypeptides (p74, p76, p78, p82, p88, and
p147) all require the presence of RNA in order to associ-
ate with Exu.
To confirm that the 57-kD polypeptide was a bona fide
Exu-associated protein, we used a different purification
strategy to isolate Exu complexes. Using flies that express
Exu with an NH2-terminal GFP tag and a COOH-terminal
His6 tag, extracts were subjected to a two-step purification
consisting of binding to an Ni-NTA column, elution with
imidazole, and then immunoprecipitation with the anti-
GFP antibody (Fig. 3). The 57-kD protein consistently
copurified stoichiometrically with GFP-Exu-His6 through
this two-step affinity purification, confirming that it is a
true Exu-associated polypeptide. The other polypeptides
in the 74–82 kD range were identified in some of our prep-
arations, but their presence and amount was highly vari-
able, possibly due to RNA degradation during the proce-
dure or instability of the complex during imidazole elution
from the column.
To identify the 57-kD Exu-associated protein, we mi-
Figure 2. Immunoprecipitation of Exu-associated proteins.
Immunoprecipitations of GFP-Exu extracts were performed with
either anti-GFP antibodies or rabbit IgG. GFP-Exu and seven
additional polypeptides (arrows) coimmunoprecipitate with
anti-GFP antibodies, but not with the rabbit IgG control. RNase A
treatment of the extracts during the immunoprecipitation shows
that six of the associated polypeptides (grey arrows) require the
presence of RNA to coimmunoprecipitate with GFP-Exu,
whereas p57 (dark arrow) does not. Two additional proteins,
p110 and p45, are also present in some immunoprecipitations (as-
terisks). p110 only associates with Exu nonspecifically in the ma-
jority of immunoprecipitation reactions. p45 was found to be a
proteolytic fragment of p57 by microsequence analysis. Migra-
tion of molecular weight standards by SDS-PAGE are indicated
on the right.
Figure 3. Purification of GFP-Exu-His6 by metal affinity chroma-
tography and GFP antibody immunoprecipitation. Shown are the
initial load, the flow through (FT) from the Ni-NTA column, two
wash steps, the imidazole eluate (Eluate), and anti-GFP immu-
noprecipitation from the Ni-NTA eluate (GFP IP). p57 copuri-
fies with GFP-Exu-His6 through this procedure. Details of the
purification procedures are found in Materials and Methods. Mi-
gration of molecular weight standards SDS-PAGE are indicated
on the left.The Journal of Cell Biology, Volume 148, 2000 432
crosequenced three tryptic peptides from the purified
protein. The sequence from two of the three peptides
matched a previously identified protein, the product of the
yps gene (Fig. 4 A). Yps is a member of the cold shock
family of RNA-binding domain proteins and was identi-
fied as part of a degenerate PCR screen to identify cold
shock domain containing genes from Drosophila melano-
gaster (Thieringer et al., 1997). However, the third peptide
only matched the Yps sequence in a reading frame other
than the published open reading frame. To rule out the
possibility that yps expression is subject to ribosomal
frameshifting or RNA editing, we obtained and sequenced
six independent yps ESTs (Berkeley Drosophila Genome
Project/Howard Hughes Medical Institute EST Project,
unpublished). Our sequence revealed that the original yps
sequence contained several sequencing errors and that the
correct open reading frame contains all three microse-
quenced peptides (Fig. 4 A). The cold shock domain of
Yps shows extensive sequence identity to other cold shock
domain proteins (Fig. 4 B). This domain has been shown
in several studies to bind RNA, although its ability to rec-
ognize specific substrates remains uncertain (Murray,
1994; Bouvet et al., 1995; Matsumoto et al., 1996). Beyond
the cold shock domain, Yps exhibited no significant ho-
mology to any other protein except YB-1, a cold shock do-
main protein from Drosophila silvesteris (AAC06034).
Since the YB-1 protein is 70% identical to Yps across the
entire length of the protein, it is likely to be a true
ortholog of Yps. No function was assigned to either YB-1
or Yps in these prior studies.
Yps Is a Component of the Exu Complex
To further characterize Yps, we prepared affinity purified
antibodies against bacterially expressed Yps (amino acids
1–160). These antibodies recognized the 57-kD Yps pro-
tein in crude extracts by immunoblot (Fig. 5 A). Using the
Yps antibody, we found that Yps comigrates with Exu in
sucrose gradients and is distributed broadly in the 20–60 S
size range (Fig. 5 B). To rule out the possibility that Exu
and Yps are components of distinct complexes of similar
size, GFP-Exu was immunoprecipitated from individual
gradient fractions and immunoblotted with the Yps anti-
body (Fig. 5 C). This experiment showed that Exu and Yps
coimmunoprecipitate together across the gradient, arguing
strongly that Exu and Yps are part of the same complex.
To provide further evidence for an Exu–Yps complex,
we immunoprecipitated GFP-Exu extracts with our anti-
Yps polyclonal antibody. In agreement with our previous
immunoprecipitation results, immunoblots showed that
GFP-Exu specifically coimmunoprecipitates with Yps (Fig.
5 D). However, immunoblots showed only a weak GFP-
Exu band in the Yps immunoprecipitate. The inefficient
coimmunoprecipitation of GFP-Exu with Yps is probably
due to the fact that our anti-Yps antibody may displace
Exu from the complex, since it was raised against the Exu-
binding region of Yps (discussed below; Fig. 6). The Yps
immunoprecipitates also contained the same six proteins
(p74, p76, p78, p82, p88, and p147) that strongly coimmu-
noprecipitated with GFP-Exu and were present in similar
stoichiometries (Fig. 5 E). The coimmunoprecipitation of
these six proteins with Yps was diminished by RNase
treatment, as was observed in our previous Exu immuno-
precipitation experiments (Fig. 5 E). The ability of Yps
and Exu antibodies to coimmunoprecipitate the same set
of polypeptides argues that these proteins are bona fide
components of the Exu-Yps complex.
Exuperantia Binds Directly to the NH2-Terminal 
Region of Yps in the Absence of RNA or Other Proteins
The coimmunoprecipitation of Exu and Yps after RNase
A treatment suggested, but did not prove, that Exu and
Yps bound directly to each other. To test this idea, we ex-
amined the Exu–Yps interaction in an in vitro translation
reaction (Fig. 6). Myc-tagged Yps was in vitro translated in
the presence of [35S]methionine and then added to an un-
labeled in vitro translation of HA-tagged Exu. Before mix-
ing, each translation reaction was treated with RNase A to
eliminate any residual RNA from the translation reaction.
When HA–Exu was immunoprecipitated from the com-
bined mixture with the anti-HA antibody, the 35S-labeled
myc-Yps protein was coimmunoprecipitated. The amount
of myc-Yps that coimmunoprecipitated with HA–Exu was
approximately half of the amount of myc-Yps that was im-
munoprecipitated directly with the anti-myc antibody,
showing that Yps is predominantly bound to Exu under
these experimental conditions. These results demonstrate
that the additional RNA and protein components of the
Figure 4. Sequence of p57/Yps, a cold shock domain RNA bind-
ing protein. (A) The predicted protein sequence of Yps deter-
mined from sequencing of six ESTs from the Berkeley Dro-
sophila Genome Project. Solid lines highlight the peptides
obtained by microsequencing of p57. Mismatches between the
translated sequence and the microsequenced peptides are in
lower case. The dashed line delineates the cold shock domain.
Amino acid residue number are shown on the right. (B) Se-
quence alignment of the cold shock domain of Yps with other
cold shock domains from human (DBPA), Xenopus (YB1), gold-
fish (YB2), and Aplysia (YB1) proteins. Residues that are identi-
cal in all five proteins are highlighted. Residues that are identical
or similar in four of the five proteins are shown in upper case and
less well-conserved residues are in lower case.Wilhelm et al. RNP Complex Involved in mRNA Localization 433
native Exu complex are not required for Exu and Yps to
associate stably with each other (Fig. 6).
To determine which region of Yps is important for bind-
ing to Exu, deletions of myc-Yps were assayed for their
ability to bind HA–Exu in vitro. The NH2-terminal region
(1–160 amino acids) of Yps, which contains the cold shock
domain, bound to Exu at the same efficiency as the full-
length protein (Fig. 6). However, the minimal cold shock
domain (56–151 amino acids) did not bind to Exu in this
assay (Fig. 6), suggesting that the sequences flanking the
cold shock domain are likely to contribute to the Exu-
binding site. The proline-rich COOH terminus of Yps pre-
sumably is not sufficient for binding. However, this could
not be assessed experimentally, since this region did not
stably express either in vitro or in bacteria.
osk mRNA Is Present in the Exu–Yps Complex
The shift in the size of the Exu–Yps complex after RNase
treatment suggested that it might be directly involved in
mRNA localization. To test this idea, we immunoprecipi-
tated either Exu or Yps from extracts and analyzed the
pellet for the presence of various localized (bcd, osk, nos)
messages and a housekeeping message (phosphoglyceroki-
nase [pgk]). We analyzed these four transcripts because
each gene appears in the EST database (Berkeley Dro-
sophila Genome Project/Howard Hughes Medical Insti-
tute EST Project, unpublished) at roughly equivalent fre-
quencies, indicating that these messages are likely to be
present in comparable amounts. Furthermore, bcd, osk,
and  nos are localized differently during oogenesis. bcd
mRNA is localized to the anterior of the oocyte beginning
at stage 7 of oogenesis; osk mRNA is localized transiently
to the anterior of the oocyte during stages 8/9 and is exclu-
sively localized to the posterior by the end of stage 9; nos
mRNA is localized to the posterior of the oocyte during
late oogenesis. Using a RT-PCR assay, we amplified bcd,
osk,  nos, and pgk transcripts from total RNA from ex-
tracts (Fig. 7 A). When GFP-Exu immunoprecipitates
were analyzed by RT-PCR, osk transcript (Fig. 7 B), but
none of the others (data not shown) was amplified by RT-
PCR. The identical result was obtained when RT-PCR
was performed on immunoprecipitations with the anti-Yps
antibody, whereas control IgG immunoprecipitations
yielded no osk RT-PCR signal (Fig. 7 B). To rule out arti-
facts due to signal saturation, we serially diluted the RT
Figure 5. Yps sedimentation
and identification of associ-
ated proteins. (A) Immuno-
blot of total fly extract with
affinity purified anti-Yps an-
tibody. Migration of molecu-
lar weight standards by SDS-
PAGE are indicated. (B)
Sedimentation of Exu and
Yps in extracts made from
frozen GFP-Exu expressing
flies through a 5–40% sucrose
gradient. Both Exu and Yps,
detected by immunoblot, sed-
iment broadly with the peak
centered at 25–30 S. (C) Im-
munoblot of Exu and Yps in
anti-GFP immunoprecipita-
tions of a 5–40% sucrose den-
sity gradient loaded with
extract made from frozen
GFP-Exu expressing flies.
Both Exu and Yps coimmu-
noprecipitate together across
the gradient, indicating that
they are both part of the same
complex. The decrease in sig-
nal in the fraction at 30 S is
due to poor recovery from
that immunoprecipitation re-
action. (D) Immunoblot for
Exu and Yps in immunopre-
cipitates from GFP-Exu ex-
tract using anti-GFP (GFP), anti-Yps (YPS), or rabbit IgG (IgG) antibodies. Exu coimmunoprecipitates with Yps, although the signal is
not as robust as the Exu signal in the anti-GFP immunoprecipitation. This is likely due to the fact that the anti-Yps antibody was raised
against the Exu binding region of Yps and hence, may displace Exu from the complex. (E) Coomassie-stained SDS-PAGE gel of immu-
noprecipitates from GFP-Exu fly extracts using anti-GFP, anti-Yps, or rabbit IgG antibodies. Dark arrows indicate GFP-Exu and Yps.
Grey arrows indicate the six polypeptides that are present in both anti-GFP and anti-Yps immunoprecipitates, but are absent from both
immunoprecipitates when RNase-treated extracts are used (see Materials and Methods). Migration of molecular weight standards by
SDS-PAGE are indicated.The Journal of Cell Biology, Volume 148, 2000 434
product from our immunoprecipitations before conduct-
ing the PCR. osk mRNA was consistently detected in the
10-, 100-, and 1,000-fold dilutions of the RT product, and
the signal decreased with increasing dilution (Fig. 7 B).
This result indicates that the PCR reaction is approxi-
mately in the linear range and that signal saturation is not
a factor in our assay. Therefore, the RT-PCR assay dem-
onstrates that both Yps and Exu are associated with a
complex that contains osk mRNA. This was an unantici-
pated result, since previous genetic studies only reported a
role for exu in the localization of bcd mRNA to the ante-
rior of the oocyte. We cannot rule out that the Exu–Yps
complex contains bcd mRNA, since our negative result
could reflect technical difficulties, such as poor bcd mRNA
stability. However, our RT-PCR results suggested the un-
anticipated possibility that exu is involved in posterior
mRNA localization.
Yps Colocalizes with Exu in Oocytes and Nurse Cells 
and Accumulates at the Posterior Pole
during Mid-Oogenesis
To learn more about the in vivo role of Yps in RNA local-
ization, Drosophila ovaries were labeled with affinity puri-
fied antibodies to the NH2 terminus (1–160 amino acids)
of Yps. Immunofluorescence staining revealed a strong
Yps signal in both the germ cells and follicle cells of devel-
oping egg chambers (Fig. 8). In contrast, labeling with sec-
ondary antibody alone produced a much weaker back-
ground signal (data not shown). This result, together with
the specificity of our anti-Yps antibody by immunoblot
(Fig. 5 A), argues that the staining we observe is specific
for Yps. Examination of different stage egg chambers
(for staging see Spradling, 1993) revealed that Yps accu-
mulates in the oocyte during stages 1–7. This signal was
stronger at the posterior of the oocyte in early stages, al-
though it was also present throughout much of the oocyte
cytoplasm (Fig. 8 A). In both early and midstage egg
chambers, Yps exhibited a particulate staining that was
frequently concentrated around the nurse cell nuclei (Fig.
8 B). At stages 8 and 9, faint anterior localization was
sometimes apparent in the oocyte (Fig. 8 C), and during
stages 9 and 10 Yps accumulated at the posterior of the
oocyte (Fig. 8, C and D).
The localization of Yps during oogenesis was very simi-
lar to the previously observed distribution of GFP-Exu
(Wang and Hazelrigg, 1994). To compare the distributions
of Exu and Yps directly, we immunostained Yps in egg
chambers expressing GFP-Exu. Individual particles con-
taining both proteins were detected in the nurse cells
(Fig. 8, E and F). The early accumulation of Yps in the oo-
cyte (stages 1–7), its accumulation at the oocyte anterior
(stages 8 and 9), and its later localization to the posterior
pole (stages 9 and 10) all coincide with the localization of
Exu protein and osk mRNA (Ephrussi et al., 1991; Kim-
Ha et al., 1991; Wang and Hazelrigg, 1994). The agree-
ment between our biochemical and in vivo localization
studies further supports a role for the Exu–Yps complex in
the localization of osk mRNA. This hypothesis was tested
directly by genetic studies, as described below.
exu Mutants Have Defects in osk mRNA Localization
Whole mount in situ hybridization was performed on ova-
ries from wild-type (Oregon R) and exu null (exuSCO2/
Df[2R]MK1) females to determine whether exu is re-
Figure 6. Binding of Exu and Yps in in vitro translation reac-
tions. Autoradiogram of in vitro translation products of myc-
tagged Yps (myc-YPS; lane 1); myc-tagged NH2-terminal Yps,
amino acids 1–160, (myc-NYPS; lane 2); and myc-tagged cold
shock domain of Yps, amino acids 56–151, (myc-CSD; lane 3).
Shown are the in vitro translation products (35S-YPS IVT), im-
munoprecipitations with the anti-myc antibody (IVT 1 a-Myc
IP), and anti-HA immunoprecipitations of unlabeled HA-tagged
Exu mixed with 35S-labeled in vitro translations (IVT 1 Cold
HA–Exu 1 a-HA IP). The lower band present in the in vitro
translation and cold HA–Exu reactions is a proteolytic product
of Yps, since it is not present in our anti-myc immunoprecipita-
tions of Yps. These experiments show that Exu binds directly to
the NH2-terminal domain of Yps.
Figure 7. Amplification of osk mRNA by RT-PCR from the
Exu-Yps complex. (A) RT-PCR of bcd, osk, nos, and pgk from
5 mg of total mRNA isolated from GFP-Exu extracts. All tran-
scripts are easily detected in total mRNA. (B) RT-PCR using
osk-specific primers from RNA isolated from immunoprecipi-
tates of GFP-Exu fly extract using anti-GFP, anti-Yps, or rabbit
IgG. The RT reaction was diluted 10-, 100-, or 1,000-fold before
the PCR step. In contrast to the signal observed with osk primers,
bcd, nos, and pgk primers did not amplify any detectable signal
from the same material (data not shown). Details of this proce-
dure are found in Materials and Methods.Wilhelm et al. RNP Complex Involved in mRNA Localization 435
quired for any aspect of osk mRNA localization. In ova-
ries from wild-type females, osk mRNA is often concen-
trated in apical patches in the nurse cells of stage 9 and 10
egg chambers (Pokrywka and Stephenson, 1995) (Fig. 9
A). In contrast, osk mRNA was dispersed in the nurse
cells of exu egg chambers of the same stages (Fig. 9 B).
Thus, exu is required for osk mRNA to be correctly local-
ized within nurse cells. Interestingly, bcd mRNA is also lo-
calized to apical patches in the nurse cells in an exu-depen-
dent manner (St Johnston et al., 1989). Although the
functional significance of this nurse cell localization is un-
known, the fact that exu mutants disrupt this localization
for both osk and bcd mRNAs indicates that at least some
of the components required for this localization are com-
mon to both transcripts.
exu mutants also caused a partial defect in osk mRNA
localization to the posterior pole. In ovaries from wild-
type females, a strong osk mRNA signal was detected at
the posterior pole in 90% (n 5 90) of wild-type stage 9 and
stage 10 oocytes (Fig. 9 C); the remainder (10%) showed
reduced (9%) or barely detectable (1%) posterior osk
mRNA signal. In contrast, only 64% of stage 9 and stage
10 egg chambers from exu mutants (n 5 210) showed an osk
mRNA signal at the posterior of the oocyte, and this signal
was consistently weaker than that observed in the wild-
type egg chambers; the remainder (36%) showed reduced
(23%), barely detectable (8%) (Fig. 9 D), or no (5%) pos-
terior osk mRNA signal. Thus, mutations in exu cause a
defect in the amount of osk mRNA that is localized to the
posterior pole during stages 9 and 10 of oogenesis.
Discussion
Although mRNA localization in Drosophila has been the
subject of extensive genetic analysis, only a few attempts
have been made to characterize biochemically the proteins
Figure 8. Yps accumulates at the posterior pole during mid-oogenesis and colocalizes with Exu within the ovary. Wild-type (Oregon
R) ovaries were labeled with anti-Yps antibody (see Materials and Methods). (A) In previtellogenic stages, Yps is most concentrated in
the oocyte (arrows). (B) In both early and midstage egg chambers, Yps is present in particles that cluster around the nurse cell nuclei
(arrow). (C) At stage 9, Yps continues to be concentrated in particles in the nurse cell cytoplasm, while it begins to accumulate at the
posterior pole and anterior margin (arrows) of the oocyte. (D) During stage 9, Yps is restricted to the posterior pole of the oocyte (ar-
row). Yps is also highly expressed in the follicle cells, the somatic cells that surround each egg chamber, during all stages of oogenesis,
although this is not visible in all images due to the plane of focus. For colocalization studies (E and F), ovaries from flies carrying a gfp-
exu transgene were labeled with an anti-Yps antibody detected with a rhodamine-tagged secondary antibody. (E) In the nurse cells of a
stage 10 egg chamber, Yps is localized to perinuclear particles that colocalize with (F) GFP-Exu particles.The Journal of Cell Biology, Volume 148, 2000 436
associated with localized messages. In this study, we have
demonstrated that Exu, a protein shown by genetic studies
to be involved in mRNA localization, is part of a large
RNase-sensitive complex. Through a combination of af-
finity chromatography and immunoprecipitation experi-
ments, we have uncovered seven proteins associated with
the Exu complex, one of which is a new RNA-binding pro-
tein, Yps.
To our knowledge, this is the first isolation of a native
RNP complex involved in RNA localization. There are
several pieces of evidence that argue against the Exu-con-
taining complex being a biochemical artifact. First, the
complex was identified using three different antibodies for
immunoprecipitation. Second, the complex that we iso-
lated from total fly homogenates is not an artifact of mix-
ing proteins from different tissues, since it is also present
in extracts made from hand dissected ovaries. Third, Exu
and Yps also copurified after metal affinity chromatogra-
phy, and the two proteins interact in vitro in the absence of
RNA. Fourth, Exu and Yps colocalize by immunofluores-
cence indicating that they form a complex in vivo. Fifth,
Exu, Yps, and osk mRNA all show a transitory accumula-
tion at the anterior in mid-oogenesis and then colocalize at
the posterior pole. Finally, the relevance of the biochemi-
cal association with osk mRNA is supported by genetic ex-
periments showing a mislocalization of osk mRNA in exu-
null mutants. Although further genetic analysis of Yps and
the other proteins in the complex will provide additional
insights into this problem, the current combination of bio-
chemical cofractionation, in vivo colocalization, and ge-
netic analysis argues for a direct role of Exu and its associ-
ated proteins in mRNA localization.
The Role of the Exu Complex in mRNA Localization
Previous genetic work implicated exu in mRNA localiza-
tion, but did not address whether Exu plays a direct or in-
direct role in the localization process (Berleth et al., 1988;
St Johnston et al., 1989; Macdonald et al., 1991; Marcey
et al., 1991). This study supports a direct involvement for
Exu, since we show that Exu is part of a large RNase-sen-
sitive complex and interacts directly with an RNA-binding
protein. Furthermore, the association of osk mRNA with
the Exu complex establishes a physical connection be-
tween Exu and a localized mRNA. The biochemical char-
acteristics of our large Exu complex also likely reflect
the properties of Exu in vivo. Exu has been shown to be
part of large particles by both GFP fluorescence (Wang
and Hazelrigg, 1994) and immunoelectron microscopy
(Wilsch-Brauninger et al., 1997). Moreover, Exu and Yps,
which are associated components in our biochemically iso-
lated complex, also colocalize in particles within the nurse
cells and oocytes.
The identification of osk mRNA in the Exu–Yps com-
plex was surprizing, given the pronounced anterior pat-
terning defects associated with exu mutants (Schupbach
and Wieschaus, 1986). However, a role for Exu in osk
mRNA localization is consistent with several other find-
ings. First, previous work has shown that Exu accumulates
at both the anterior and posterior poles of the oocyte
(Marcey et al., 1991; Wang and Hazelrigg, 1994). Second,
osk mRNA transiently accumulates at the anterior pole
along with bcd mRNA before its transport to the posterior
(Ephrussi et al., 1991; Kim-Ha et al., 1991). Finally, one of
the effects of exu mutants was to disrupt the localization of
osk mRNA to apical patches within nurse cells. This defect
is identical to the nurse cell localization defect described
previously for bcd mRNA in exu mutants (St Johnston et
al., 1989) and suggests that this step in the localization
pathway may be common to both transcripts.
One of the reasons that exu mutants have not been ex-
amined previously for defects in osk mRNA localization is
that only a small percentage of embryos from exu mothers
display posterior patterning defects (Schupbach and Wie-
schaus, 1986). Our examination of exu mutants revealed
that the amount of osk mRNA localized to the posterior
pole is decreased in these mutants, suggesting that exu
plays a role in localizing osk mRNA within oocytes. How-
ever, as this defect is only partially penetrant, Exu-depen-
dent posterior localization within the oocyte may be re-
dundant with other localization mechanisms. In addition,
the posterior patterning defects associated with the de-
crease in osk mRNA localization in exu mutants during
stages 9 and 10 of oogenesis may be rescued by local-
ization of osk mRNA during cytoplasmic streaming
later in oogenesis. In support of this idea, Glotzer et al.
(1997) have shown that injected, fluorescently labeled
osk mRNA can be localized to the posterior at the time
when cytoplasmic streaming occurs. Such localization
most likely occurs by random motion during cytoplasmic
streaming and specific anchoring of osk mRNAs that
come in contact with the posterior pole. These multiple
mechanisms of localizing osk mRNA account for the fact
that exu mutants do not display pronounced defects in ab-
dominal patterning.
Figure 9. osk mRNA localization is disrupted in exuSCO2 egg
chambers. Whole mount in situ hybridization was performed on
egg chambers from wild-type (Oregon R) and exuSCO2 flies raised
at 188C to examine the distribution of osk mRNA. (A) In the
nurse cells of wild-type stage 10 egg chambers, osk mRNA is of-
ten concentrated in patches within the nurse cell cytoplasm. (B)
In nurse cells from stage 10 exuSCO2/Df(2R)MK1 egg chambers,
the osk mRNA signal within the nurse cells is frequently dis-
persed. (C) In oocytes from wild-type stage 10 egg chambers, osk
mRNA is highly concentrated at the posterior pole. (D) In oocytes
from stage 10 exuSCO2/Df(2R)MK1 egg chambers, the osk mRNA
signal is often reduced at the posterior pole. This particular egg
chamber is an example of an oocyte with barely detectable osk
mRNA (see text).Wilhelm et al. RNP Complex Involved in mRNA Localization 437
Previous work has shown that exu is necessary for nor-
mal  bcd mRNA localization (Berleth et al., 1988; St
Johnston et al., 1989; Pokrywka and Stephenson, 1991;
Macdonald and Kerr, 1997), although these studies did
not establish a direct connection between Exu and bcd
mRNA. Nevertheless, it was surprising that we could not
detect bcd mRNA in our Exu complex. This negative re-
sult should not be taken to indicate that bcd mRNA is not
in the complex, since it could reflect poor stability of bcd
mRNA, a weaker association of bcd mRNA with the Exu
complex, or difficulty in extracting and/or purifying RNP
particles containing bcd mRNA. Alternatively, it is possi-
ble that exu’s role in bcd localization is indirect. We are
currently trying to address these issues by using other ap-
proaches to detect specific Exu–bcd mRNA interactions.
The Role of Yps in mRNA Localization
Our biochemical studies linking Yps to Exu and osk
mRNA suggest that this RNA-binding protein plays a role
in posterior mRNA localization. This assertion is further
supported by our immunofluorescence studies showing
that Yps and osk mRNA have strikingly similar localiza-
tion patterns throughout oogenesis: both accumulate in
the early oocyte, transiently localize to the oocyte anterior
during stages 8 and 9, and then assume their final positions
at the posterior pole during stages 9 and 10 (Fig. 8)
(Ephrussi et al., 1991; Kim-Ha et al., 1991). What role
might Yps play in the localization complex? Yps belongs
to the cold shock domain family of RNA-binding proteins
that have been implicated previously in regulating transla-
tion and mRNA secondary structure (Jiang et al., 1997;
Sommerville, 1999). A notable example is FRGY2, which
is complexed with mRNAs in the Xenopus oocyte and is
thought to be important for translational silencing (Tafuri
and Wolffe, 1993; Yurkova and Murray, 1997). Yps may
serve a similar role, since osk mRNA is translationally re-
pressed until it reaches the posterior pole (Kim-Ha et al.,
1995; Macdonald and Smibert, 1996; Gunkel et al., 1998).
Interestingly, Yps must also serve a function without Exu,
since yps is expressed broadly, whereas exu expression is
limited to the germ line (Macdonald et al., 1991; Marcey
et al., 1991; Thieringer et al., 1997). It is possible that Yps
is a component of the mRNA localization machinery out-
side the germ line, since other components of the oocyte
mRNA localization machinery, such as Staufen, are also
used for mRNA localization in somatic tissues (Li et al.,
1997; Broadus et al., 1998). Determining Yps’s precise in-
volvement in transport and/or translational regulation in
the oocyte and other tissues will be resolved in the future
by mutational studies.
A Model for mRNA Transport by the Exu–Yps Complex
The pathways by which anterior- and posterior-localized
mRNAs arrive at their destinations are poorly understood,
although it is generally believed that these RNAs are rec-
ognized by different proteins and utilize distinct transport
machineries. However, we propose that anterior- and pos-
terior-localized mRNAs begin their localization process in
the nurse cells using a similar complex, with Exu serving as
a common core component (Fig. 10). In our model, one of
Exu’s functions is as a component of an mRNA transport
complex, since GFP-Exu particles have been observed to
move in a microtubule-dependent manner (Theurkauf and
Hazelrigg, 1998). Consistent with this idea, both osk and
bcd mRNA accumulate in apical patches within nurse
cells, and exu mutants disrupt this localization pattern for
both mRNAs (St Johnston et al., 1989; Pokrywka and
Stephenson, 1995) (Fig. 9 B). We also propose that the
Exu complex transports mRNAs from the nurse cells to
the oocyte as well as within the oocyte (Fig. 10), although
these transport steps also can be achieved through other
redundant mechanisms, such as nurse cell dumping and
cytoplasmic streaming (Spradling, 1993). Although the
above model places Exu as part of a transport complex, it
Figure 10. A two-step model
for sorting mRNAs to the an-
terior and posterior poles of
the oocyte. osk and bcd
mRNAs each recruit tran-
script-specific proteins (A and
P) as well as common compo-
nents, such as Exu. Exu is in-
volved in transport of osk
and bcd mRNAs from the
nurse cells to the anterior of
the oocyte (step 1). Once at
the anterior, the specific
components (A and P) sort
mRNAs so that bcd mRNA
is anchored to the anterior of
the oocyte, while osk mRNA
is transported to the poste-
rior. In this model, we have
depicted Yps as a candidate
component of osk mRNA-
specific complexes for rea-
sons described in the text.The Journal of Cell Biology, Volume 148, 2000 438
should be noted that our present data also could be ex-
plained if Exu contributes to the establishment of anchor-
ing once mRNAs reach their final destination.
After arriving in the oocyte, bcd- and osk-containing
RNPs must be sorted so that bcd becomes anchored at the
anterior, whereas osk is transported to the posterior pole.
Since Yps, Exu, bcd mRNA, and osk mRNA all first colo-
calize at the anterior (Fig. 8) (Ephrussi et al., 1991; Kim-
Ha et al., 1991; Wang and Hazelrigg, 1994; Theurkauf and
Hazelrigg, 1998), we propose that this sorting decision oc-
curs at the anterior of the oocyte (Fig. 10). Evidence for
this anterior sorting model comes from genetic studies of
staufen (stau) and tropomyosin II (TmII), which show that
these proteins do not interfere with anterior localization
but rather block the release and transport of osk tran-
scripts to the posterior (Ephrussi et al., 1991; Kim-Ha et al.,
1991; Erdelyi et al., 1995; Tetzlaff et al., 1996). The molec-
ular basis for this sorting decision is unclear, but may in-
volve modifications to the transport machinery or the re-
cruitment of additional factors.
Biochemistry of the Exu Complex: Relationship to In 
Vivo Function
Biochemical isolation of a native RNP complex pro-
vides an opportunity to identify new proteins involved in
mRNA localization, which may have been missed by ge-
netic analyses due to lethality or redundant functions.
However, a significant caveat of our approach is that our
isolated RNP particles may be heterogeneous, since our
purification strategy begins with a crude extract containing
material from egg chambers at all stages of oogenesis.
Thus, it is likely that our biochemically-isolated material
may represent a spectrum of complexes that comprise
transport intermediates from the recognition of localized
mRNAs in the nurse cells to the anchoring of the com-
plexes at the posterior poles. In addition to temporal changes
in the composition of the Exu complex, it is also possible
that multiple Exu particles exist which contain distinct
mRNA cargos.
To resolve these important issues, it will be important to
determine the molecular identity of the six RNase-sensi-
tive polypeptides in our Exu complex and determine if
they are required selectively for the localization of bcd
mRNA or osk mRNA. In addition, simultaneous observa-
tion and colocalization of GFP-tagged mRNAs (Bertrand
et al., 1998) and blue fluorescent protein–tagged protein
components of the Exu complex will reveal which mRNAs
and polypeptides are contained within the same transport
complex in vivo. This approach will also allow direct ob-
servation of mRNA transport in Drosophila for the first
time and provide a method for analyzing the changes in
RNP components during the movement of RNAs from the
nurse cell to their final destination in the oocyte.
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